The association of non-invasive skin autofluorescence measurements with cardiovascular and all-cause mortality in hemodi
- PDF / 1,301,062 Bytes
- 13 Pages / 595.276 x 790.866 pts Page_size
- 9 Downloads / 169 Views
NEPHROLOGY - ORIGINAL PAPER
The association of non‑invasive skin autofluorescence measurements with cardiovascular and all‑cause mortality in hemodialysis patients: a meta‑analysis Seshadri Reddy Varikasuvu1 · Harish Sulekar2 · Sowjanya Aloori3 · Balachandar Thangappazham4 Received: 5 March 2020 / Accepted: 15 June 2020 © Springer Nature B.V. 2020
Abstract Background This systematic review and meta-analysis were aimed to study the association of tissue accumulation of advanced glycation end products (AGEs) measured as skin autofluorescence (SAF) with cardiovascular disease (CVD), cardiovascular mortality (CVM) and all-cause mortality (ACM) in hemodialysis (HD) patients. Methods All major databases were searched for relevant studies reporting SAF in dialysis patients. Data for meta-analyses were extracted in the form of odds ratios (OR) and/or hazard ratios (HR) and the pooled overall outcomes were computed for the association of SAF with CVD, CVM, ACM in HD patients using either fixed or random effects meta-analysis based on the between-study heterogeneity. The sensitivity and meta-regression analyses were performed. Results We included nine studies in this meta-analysis. The SAF levels were associated with higher risk for cardiovascular morbidity (pooled OR = 2.59, Z = 2.30, P = 0.02), cardiovascular (pooled HR = 3.03, Z = 3.13, P = 0.002) and overall mortalities (pooled HR = 2.23, Z = 6.30, P
Data Loading...
